Researchers have identified several human antibodies that target SARS-CoV-2, the virus responsible for Covid-19, according to three papers published in the journal Science.

Several of these antibodies showed protective, neutralizing capabilities, offering promising therapeutic leads, and eight antibodies from one analysis were discovered to cross-react with a related bat-specific coronavirus.